Nilsine Partners’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
LMFP
ATO
HCM
AAMU
FWCM
Nilsine Partners's ABBV Position: Q2 2026 in Review
Nilsine Partners increased its AbbVie (ABBV) stake by 5.4% in Q2 2026, buying an estimated $112K and bringing the position to 10,103 shares worth $2.54M. The position accounts for 0.18% of the portfolio, ranked #128.
Nilsine Partners first reported a position in ABBV in Q1 2023 and has held it in 14 quarters since. 1,476 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Nilsine Partners held 10,103 shares of AbbVie worth $2.54M as of Q2 2026.
- Nilsine Partners bought 521 AbbVie shares in Q2 2026, an estimated $112K.
- AbbVie made up 0.18% of Nilsine Partners's portfolio in Q2 2026, its #128 holding.
- Nilsine Partners first reported a position in AbbVie in Q1 2023 and has held it in 14 quarters since.
- 1,476 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Nilsine Partners's 13F filing for Q2 2026, filed 24 Jul 2026.